KJIM :: Korean Journal of Internal Medicine

Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications

Journal of Korean Medical Science.2024;[Epub] CrossRef

Predictors of Successful First-Line Helicobacter pylori Eradication with Fluoroquinolones in Pakistan: A Prospective Exploration of Demographic and Clinical Factors

Sumaira Khadim, Iyad Naeem Muhammad, Tanveer Alam, Shahnaz Usman, Hina Rehman, Sajjad Haider

Effectiveness of eradication therapy for Helicobacter pylori infection in Africa: a systematic review and meta-analysis

Sintayehu Fekadu, Hizkel Engiso, Sisay Seyfe, Hisashi Iizasa, Ashebir Godebo, Serawit Deyno, Hironori Yoshiyama

Antimicrobial Resistance Molecular Mechanisms of Helicobacter pylori in Jordanian Children: A Cross-Sectional Observational Study

Salma Burayzat, Mohammad Al-Tamimi, Mohammad Barqawi, Mustafa Sabri Massadi, Jumanah Abu-Raideh, Hadeel Albalawi, Ashraf I. Khasawneh, Nisreen Himsawi, Maha Barber

Novel Mutations Conferring Amoxicillin Resistance in Helicobacter pylori in South Korea

Soon Young Park, Eun Hwa Lee, Dokyun Kim, Young Goo Song, Su Jin Jeong

The Suitability of Stool Antigen Testing in the Detection of Helicobacter pylori in a Regional and Rural Area of Australia

Timothy Wearne, Safaa Nadeem, Bruce Wilson, Kylie J. Mansfield, Caitlin Keighley, Sreedhari Thayalasekaran

Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations

Jing Yu, Yiming Lv, Peng Yang, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang

Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study

Impact of smoking on the eradication of Helicobacter pylori

Jing Yu, Peng Yang, Xiangrong Qin, Chunjian Li, Yiming Lv, Xiaoyong Wang

Helicobacter pylori eradication in renal transplant candidates

Mariana E. Maioli, Raquel F. N. Frange, Cintia M. C. Grion, Vinicius D. A. Delfino

Brazilian Journal of Nephrology.2022; 44(2): 215. CrossRef

Efficacy of Twice a Day Bismuth Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection

Jeemyoung Kim, Eun Jeong Gong, Myeongsook Seo, Hyun Il Seo, Jong Kyu Park, Sang Jin Lee, Koon Hee Han, Woo Jin Jeong, Young Don Kim, Gab Jin Cheon

Journal of Personalized Medicine.2022; 12(1): 56. CrossRef

Helicobacter pylori infection treatment in the United States: clinical consequences and costs of eradication treatment failure

Shailja Shah, Elizabeth Hubscher, Corey Pelletier, Rinu Jacob, Lydia Vinals, Rena Yadlapati

Expert Review of Gastroenterology & Hepatology.2022; 16(4): 341. CrossRef

Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection

Cheng-Yu Ho, Ting-Wen Liu, Yang-Sheng Lin, Yen-Po Chen, Ming-Jen Chen, Horng-Yuan Wang, Tai-Cherng Liou

Successful Eradication of Helicobacter pylori with 5-Day Concomitant Treatment

Eradication Rate Using a First-line Triple Therapy for Helicobacter pylori Infection in Yeongdong, Gangwon Province, Korea

Eun Jeong Gong, Chang Seok Bang, Myeongsook Seo, Hyun Il Seo, Jong Kyu Park, Sang Jin Lee, Koon Hee Han, Woo Jin Jeong, Young Don Kim, Gab Jin Cheon

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 139. CrossRef

Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study

Toshihiko Kakiuchi, Muneaki Matsuo, Hiroyoshi Endo, Yasuhisa Sakata, Motohiro Esaki, Takahiro Noda, Ichiro Imamura, Kazutoshi Hashiguchi, Shinichi Ogata, Yasuhiko Fujioka, Keiichiro Hanada, Kayoko Fukuda, Masaya Yoshimura, Tetsuro Kajiwara, Kentaroh Yamam

A 10- or 14-day Bismuth-containing Quadruple Therapy as a First-line Helicobacter pylori Eradication Therapy: A Systematic Review and Meta-analysis

Sung Eun Kim, Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(1): 48. CrossRef

Seven-day triple therapy is sufficient to eradicate infection caused by Helicobacter pylori without 23S rRNA point mutation

Jung Wook Lee, Su Jin Kim, Cheol Woong Choi, Hyeong Jin Kim, Dae Hwan Kang, Hyung Wook Kim, Su Bum Park, Hyeong Seok Nam, Dae Gon Ryu

Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology

Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Nira

Indian Journal of Gastroenterology.2021; 40(4): 420. CrossRef

Evaluation of the Effectiveness of Helicobacter pylori Eradication Regimens in Lithuania during the Years 2013–2020: Data from the European Registry on Helicobacter pylori Management (Hp-EuReg)

Paulius Jonaitis, Juozas Kupcinskas, Olga P. Nyssen, Ignasi Puig, Javier P. Gisbert, Laimas Jonaitis

Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori

Sang Yoon Kim, Jae Myung Park, Chul-Hyun Lim, Hye Ah Lee, Ga-Yeong Shin, Younghee Choe, Yu Kyung Cho, Myung-Gyu Choi

Vaccine development against Helicobacter pylori: from ideal antigens to the current landscape

Irineu Dos Santos Viana, Maria Luísa Cordeiro Santos, Hanna Santos Marques, Vinícius Lima de Souza Gonçalves, Breno Bittencourt de Brito, Filipe Antônio França da Silva, Natália Oliveira e Silva, Fillipe Dantas Pinheiro, Adriano Fernandes Teixeira, Davi T

Expert Review of Vaccines.2021; 20(8): 989. CrossRef

Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study

Jin Young Yoon, Min Seob Kwak, Jung Won Jeon, Jae Myung Cha

The Tohoku Journal of Experimental Medicine.2021; 255(1): 41. CrossRef

Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo

Jia Di, Jun Zhang, Lei Cao, Ting-ting Huang, Jun-xia Zhang, Yan-ni Mi, Xue Xiao, Ping-ping Yan, Man-li Wu, Tong Yao, Dong-zheng Liu, Jing Liu, Yong-xiao Cao

Antimicrobial Agents and Chemotherapy.2020;[Epub] CrossRef

The Prevalence of Multidrug Resistance of Helicobacter pylori and Its Impact on Eradication in Korea from 2017 to 2019: A Single-Center Study

Jae Yong Park, Tae-Seop Shin, Ji Hyun Kim, Hong Jip Yoon, Beom Jin Kim, Jae Gyu Kim

Efficacy of Seven-day High-dose Esomeprazole-based Triple Therapy versus Seven-day Standard Dose Non-esomeprazole-based Triple Therapy as the First-line Treatment of Patients with Helicobacter pylori Infection

Young Dal Lee, Sung Eun Kim, Seun Ja Park, Moo In Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jiyun Song

The Korean Journal of Gastroenterology.2020; 76(3): 142. CrossRef

Levofloxacin-Based Regimen Versus Bismuth Quadruple Regimen for Helicobacter pylori Eradication in Kurdistan Region, Iraq

Nawfal R Hussein, Shahram A Mirkhan, Ali A Ramadhan, Ramdhan S Issa, Ibrahim A. Naqid, Bawer Yassin, Sollen S Hasso, Reving S Salih, Shaimaa A Mahmood

Avicenna Journal of Clinical Microbiology and Infection.2020; 7(3): 81. CrossRef

Accuracy of theHelicobacter pyloridiagnostic tests in patients with peptic ulcer bleeding: a systematic review and network meta-analysis

Nóra Vörhendi, Alexandra Soós, Marie Anne Engh, Benedek Tinusz, Zsolt Szakács, Dániel Pécsi, Alexandra Mikó, Patrícia Sarlós, Péter Hegyi, Bálint Eröss

Therapeutic Advances in Gastroenterology.2020; 13: 175628482096532. CrossRef

Gastric juice‐based PCR assay: An alternative testing method to aid in the management of previously treated Helicobacter pylori infection

Meng‐Shu Hsieh, Chung‐Jung Liu, Wen‐Hung Hsu, Chia‐Jung Li, Pei‐Yun Tsai, Huang‐Ming Hu, Hsiang‐Yao Shih, Chien‐Yu Lu, Fang‐Jung Yu, Fu‐Chen Kuo, Deng‐Chyang Wu, Chao‐Hung Kuo

Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy

Sung Eun Kim, Ji Hun Roh, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jae Joon Heo

The Korean Journal of Gastroenterology.2019; 73(1): 26. CrossRef

Can Aminoglycosides Be Used as a New Treatment forHelicobacter pylori?In vitroActivity of Recently IsolatedHelicobacter pylori

Kyoung Hwa Lee, Soon Young Park, Su Jin Jeong, Da Hyun Jung, Jie-Hyun Kim, Seok Hoon Jeong, Il-Mo Kang, Young Goo Song

Infection & Chemotherapy.2019; 51(1): 10. CrossRef

Predictors of triple therapy treatment failure among H. pylori infected patients attending at a tertiary hospital in Northwest Tanzania: a prospective study

Hyasinta Jaka, Andreas Mueller, Christa Kasang, Stephen E. Mshana

Comparative Study between Two Triple-therapy Regimens in Treating Helicobacter pylori: Related Peptic Ulcer Disease

Gokul D Yatheendranathan, Sudhakar Ankaiya, J Lalith Kumar

SBV Journal of Basic, Clinical and Applied Health Science.2019; 2(3): 108. CrossRef

Erradicación de la infección por Helicobacter pylori con una nueva terapia cuádruple basada en bismuto en la práctica clínica

Elena Pérez-Arellano, María Isabel Rodriguez-Garcia, Ana Belen Galera Rodenas, Emilio de la Morena-Madrigal

Gastroenterología y Hepatología.2018; 41(3): 145. CrossRef

Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study

Scandinavian Journal of Gastroenterology.2018; 53(2): 130. CrossRef

Sex differences in urea breath test results for the diagnosis of Helicobacter pylori infection: a large cross-sectional study

Ido Eisdorfer, Varda Shalev, Sophy Goren, Gabriel Chodick, Khitam Muhsen

Eradication of Helicobacter pylori infection with a new bismuth-based quadruple therapy in clinical practice

Elena Pérez-Arellano, María Isabel Rodriguez-Garcia, Ana Belen Galera Rodenas, Emilio de la Morena-Madrigal

Gastroenterología y Hepatología (English Edition).2018; 41(3): 145. CrossRef

IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION

Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALH

Arquivos de Gastroenterologia.2018; 55(2): 97. CrossRef

Clinical relevance of point mutations in the 23S rRNA gene in Helicobacter pylori eradication

Chang-Geun Park, Seohyeon Kim, Eun-Ju Lee, Hyo-Sung Jeon, Seungwoo Han

Peptide Nucleic Acid Probe-Based Analysis as a New Detection Method for Clarithromycin Resistance inHelicobacter pylori

Da Hyun Jung, Jie-Hyun Kim, Su Jin Jeong, Soon Young Park, Il-Mo Kang, Kyoung Hwa Lee, Young Goo Song

Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication

Ji Young Chang, Ki-Nam Shim, Chung Hyun Tae, Ko Eun Lee, Jihyun Lee, Kang Hoon Lee, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Sung-Ae Jung

Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?

Diogo Branquinho, Nuno Almeida, Carlos Gregório, José Eduardo Pina Cabral, Adriano Casela, Maria Manuel Donato, Luís Tomé

Helicobacter pylori Eradication Rate in Patients with Diabetes

Jiyeon Yoo, Yeong Ji Yu, Gumin Cho, Hongkwon Oh, Seung Hyun Oh, Tae Ho Kim, Jung Hwan Oh

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2017; 17(2): 83. CrossRef

Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial

Mercedes Ramas, Maria G. Donday, Adrian G. McNicholl, Javier P. Gisbert

Gastroenterología y Hepatología.2017; 40(10): 658. CrossRef

The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure inHelicobacter pyloriEradication

Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi

The Korean Journal of Gastroenterology.2017; 70(2): 72. CrossRef

Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes

Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Hae Koo Kim, Young Dal Lee

World Journal of Gastroenterology.2017; 23(6): 1059. CrossRef

Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial

Mercedes Ramas, Maria G. Donday, Adrian G. McNicholl, Javier P. Gisbert

Gastroenterología y Hepatología (English Edition).2017; 40(10): 658. CrossRef

A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysis

Binjie Hu, Fuju Zhao, Shiwen Wang, Michal A Olszewski, Haipeng Bian, Yong Wu, Mimi Kong, Lingli Xu, Yingxin Miao, Yi Fang, Changqing Yang, Hu Zhao, Yanmei Zhang

The Influence of Iron Deficiency onHelicobacter pyloriEradication

Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Kwang Il Seo, Seong Kyeong Lim, Jin Kyu Jung, Hyeon Jin Kim, Go Eun Yeo, Sung Chan Jeon, Duk Song Cho, You Jin Han

The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2016; 16(2): 82. CrossRef

First‐line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan

Cheng‐En Tsai, Chih‐Ming Liang, Chen‐Hsiang Lee, Yuan‐Hung Kuo, Keng‐Liang Wu, Yi‐Chun Chiu, Wei‐Chen Tai, Seng‐Kee Chuah

The Kaohsiung Journal of Medical Sciences.2016; 32(8): 397. CrossRef

Update on prevention and treatment of Helicobacter pylori infection

World Chinese Journal of Digestology.2016; 24(16): 2454. CrossRef